Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression
Shivani Kamdar(Mount Sinai Hospital), Bharati Bapat(Mount Sinai Hospital)
Cited by 44
Related Papers
Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database
|Nature Genetics|2013|476
The <i>FGFR3</i> Mutation is Related to Favorable pT1 Bladder Cancer
|The Journal of Urology|2011|102
Prognostic value of molecular markers, sub‐stage and European Organisation for the Research and Treatment of Cancer risk scores in primary T1 bladder cancer
|British Journal of Urology|2012|64
Molecular and clinical support for a four-tiered grading system for bladder cancer based on the WHO 1973 and 2004 classifications
|Modern Pathology|2014|47
308 THE FGFR3 MUTATION IS RELATED TO FAVORABLE PT1 BLADDER CANCER
|European Urology Supplements|2009|12